Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Danaher    DHR

DANAHER (DHR)

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

Danaher 1Q Profit Rises 43% On Strong Revenue Growth

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/19/2012 | 12:54pm CEST

Danaher Corp.'s (>> Danaher Corporation) first-quarter earnings rose 43% as the diversified manufacturer's revenue growth got a boost from acquisitions.

For the current quarter, Danaher forecast per-share earnings of 76 cents to 81 cents, including anticipated dilution of a penny from its recent deal to acquire X-Rite Inc. (XRIT). Analysts polled by Thomson Reuters expected per-share earnings of 82 cents.

The company narrowed its 2012 per-share earnings estimate to $3.25 to $3.35 from its previous range of $3.20 to $3.35. The new forecast includes 3 cents of anticipated dilution related to X-Rite.

Danaher has remained acquisitive, mostly focusing its efforts on medical technology, testing and measurement and dental equipment. The acquisition of Beckman Coulter last year for $5.78 billion was Danaher's largest deal and gives the company a stronger foothold in the growing diagnostics industry.

More recently Danaher reached a $478 million deal for color-measurement technology company X-Rite in a move Danaher expects will complement its Esko digital design capabilities and further its lead in the product identification industry.

President and Chief Executive H. Lawrence Culp Jr. said the company was encouraged by the quarter-to-quarter business improvement and expects that core growth will accelerate in the second quarter.

Danaher reported a profit of $612.9 million, or 86 cents a share, up from $429.4 million, or 63 cents a share, a year earlier. Earnings from continuing operations were up at 73 cents from 61 cents. Danaher in January had projected earnings of 66 cents to 71 cents.

Revenue increased 31% to $4.32 billion. Excluding acquisitions and currency fluctuations, revenue was up 1.5%

Analysts recently projected $4.33 billion.

Gross margin fell to 51.8% from 53.1%.

Shares closed Wednesday at $54.69 and were inactive premarket.

-By Tess Stynes, Dow Jones Newswires; 212-416-2481; [email protected]

Stocks mentioned in the article : Danaher Corporation
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on DANAHER
06/28 DANAHER CORPORATION : ex-dividend day
06/21 DANAHER CORP /DE/ : Other Events, Financial Statements and Exhibits (form 8-K)
06/21 DANAHER : Schedules Second Quarter 2017 Earnings Conference Call
06/20 DANAHER : Announces Pricing Of Euro-Denominated Senior Notes Offering
06/19 DANAHER CORP /DE/ : Other Events, Financial Statements and Exhibits (form 8-K)
06/13 DANAHER : To present at goldman sachs global healthcare conference
06/08 DANAHER : to Present at Goldman Sachs Global Healthcare Conference
05/25 DANAHER : To Present At Bernstein Strategic Decisions Conference
05/17 Toothwash Equipment Market 2017 - a-Dec, 3M Company, Biolase, Planmeca Oy, Da..
05/15 DANAHER : To Present At Electrical Products Group Conference
More news
Sector news : Advanced Medical Equipment & Technology - NEC
06:59aDJROYAL PHILIPS : Philips Buys CardioProlific Inc for Undisclosed Sum
06/28 Philips to buy medical device maker Spectranetics for 1.9 billion euros
06/28DJROYAL PHILIPS : to Buy Spectranetics for $2.15 Billion
06/22DJROYAL PHILIPS : Philips to Buy Electrical Geodesics for GBP29 Million
06/19 PERKINELMER : to buy Germany's Euroimmun for about $1.3 billion
More sector news : Advanced Medical Equipment & Technology - NEC
News from SeekingAlpha
06/20 Danaher prices Euro debt offering
06/12 One Year Later Post Spin-Off For Danaher Corporation
06/07 Danaher downgraded to Neutral from Buy at Janney
06/05 Danaher Corporation (DHR) Presents At Bernstein's 33rd Annual Strategic Decis..
05/30 Tracking Charles Akre's Akre Capital Management Portfolio - Q1 2017 Update
Advertisement
Financials ($)
Sales 2017 17 963 M
EBIT 2017 3 320 M
Net income 2017 2 280 M
Debt 2017 8 835 M
Yield 2017 0,64%
P/E ratio 2017 24,89
P/E ratio 2018 22,53
EV / Sales 2017 3,83x
EV / Sales 2018 3,49x
Capitalization 60 020 M
More Financials
Chart DANAHER
Duration : Period :
Danaher Technical Analysis Chart | DHR | US2358511028 | 4-Traders
Full-screen chart
Technical analysis trends DANAHER
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 16
Average target price 92,3 $
Spread / Average Target 8,9%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Thomas Patrick Joyce President, Chief Executive Officer & Director
Stephen M. Rales Chairman
Daniel L. Comas Chief Financial Officer & Executive Vice President
Alan G. Spoon Independent Director
Donald Jerry Ehrlich Lead Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
DANAHER8.84%60 020
THERMO FISHER SCIENTIF..23.10%68 765
BOSTON SCIENTIFIC CORP..30.00%38 508
INTUITIVE SURGICAL49.22%34 863
ROYAL PHILIPS12.21%34 293
ILLUMINA37.74%26 480
More Results